ADRUCIL INJ 50MG/ML 500 MG / 10 ML
FLUOROURACIL : 500 MG / 10 ML · DIN 00428493 · ADRIA LABORATORIES OF CANADA LTD.
Health Canada status: CANCELLED POST MARKET
What is ADRUCIL INJ 50MG/ML?
ADRUCIL INJ 50MG/ML 500 MG / 10 ML contains FLUOROURACIL : 500 MG / 10 ML. It is listed in the Health Canada Drug Product Database under DIN 00428493, held by ADRIA LABORATORIES OF CANADA LTD., supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00428493 |
|---|---|
| Brand name | ADRUCIL INJ 50MG/ML |
| Generic / active ingredient | FLUOROURACIL : 500 MG / 10 ML |
| Manufacturer | ADRIA LABORATORIES OF CANADA LTD. |
| Strength | 500 MG / 10 ML |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01BC02 FLUOROURACIL |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Sep-1996 |
What can be used instead?
Other Canadian products sharing ATC code L01BC02 FLUOROURACIL. 6 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EFUDEX | 5 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 00330582 |
| FLUOROURACIL INJECTION | 0.5 G / 10 ML | SOLUTION | BIOLYSE PHARMA CORPORATION | MARKETED | DIN 02473763 |
| FLUOROURACIL INJECTION | 5 G / 100 ML | SOLUTION | BIOLYSE PHARMA CORPORATION | MARKETED | DIN 02473771 |
| FLUOROURACIL INJECTION | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00012882 |
| FLUOROURACIL INJECTION USP | 50 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED | DIN 02413450 |
| TOLAK | 4 % | CREAM | HILL DERMACEUTICALS INC | MARKETED | DIN 02485346 |
| ADRUCIL | 50 MG | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02063921 |
| FLUOROPLEX CREAM 1% | 1 % | CREAM | ALLERGAN HERBERT SKIN CARE DIVISION OF ALLERGAN INC. | CANCELLED POST MARKET | DIN 01982311 |
| FLUOROURACIL INJ 50MG/ML | 50 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 00891754 |
| FLUOROURACIL INJECTION | 1000 MG / 20 ML | SOLUTION | GENERIC MEDICAL PARTNERS INC | APPROVED | DIN 02476746 |
Who else supplies FLUOROURACIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLUOROURACIL appears in 63 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.